Listed by the USPTO as LEE, YIE CHIA
Tech Center 1600 • Art Units: 1642 1644 1671
This examiner grants 69% of resolved cases
LEE, YIE CHIA works in Tech Center 1600 and Art Unit 1642. The record includes 39 resolved cases and shows a 69.2% allowance rate. The median time to allowance is 1288 days, so applicants should interpret the outcome alongside a long reported prosecution timeline and a limited resolved-case record.
The interview lift is 46.6%, making interviews a significant planning consideration in the available data. The General Hospital, Bristol-Myers Squibb, and Mayo Foundation are the leading listed companies. Clark+Elbing, pH IP Law, and Baker Botts are the leading listed firms. The profile is centered on medical and pharmaceutical applicants.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17772865 | METHODS OF TREATMENT WITH ANTIBODIES AGAINST BCMA AND CD3 | Final Rejection | BRISTOL-MYERS SQUIBB COMPANY |
| 18294747 | ASSESSING AND TREATING MESOTHELIOMA | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18273395 | ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES | Non-Final OA | The General Hospital Corporation |
| 17627975 | SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER | Final Rejection | The General Hospital Corporation |
| 18271206 | MODULATION OF CD46 CELL SURFACE MARKER IN BOTH ANDROGEN RECEPTOR-POSITIVE AND NEGATIVE CANCER CELLS | Non-Final OA | The Regents of the University of California |
| 18529691 | TRANSFERRIN RECEPTOR BINDING PROTEINS | Non-Final OA | Sanofi |
| 17606306 | USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE | Non-Final OA | Viela Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy69.2% of resolved applications examined by Yie Chia Lee were allowed (39 resolved cases), compared with 38.5% across Art Unit 1642 over the last five years.
This examiner's interview lift is +46.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Yie Chia Lee took 1,288 days on average from filing to allowance.
Yie Chia Lee examines applications in Art Unit 1642 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
